Cyrus J. Lawrence LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 225 shares of the company’s stock, valued at approximately $26,000.
Several other large investors have also modified their holdings of CAH. Promus Capital LLC purchased a new stake in shares of Cardinal Health during the fourth quarter worth approximately $30,000. Lee Danner & Bass Inc. purchased a new stake in shares of Cardinal Health during the fourth quarter worth approximately $35,000. Kentucky Trust Co purchased a new stake in shares of Cardinal Health during the fourth quarter worth approximately $41,000. HHM Wealth Advisors LLC raised its stake in shares of Cardinal Health by 57.6% during the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock worth $47,000 after purchasing an additional 144 shares during the last quarter. Finally, Raleigh Capital Management Inc. raised its stake in shares of Cardinal Health by 29.6% during the fourth quarter. Raleigh Capital Management Inc. now owns 464 shares of the company’s stock worth $55,000 after purchasing an additional 106 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on the company. JPMorgan Chase & Co. upped their price objective on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Wells Fargo & Company upped their price objective on Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 4th. Bank of America raised Cardinal Health from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $132.00 to $145.00 in a report on Monday, January 6th. Morgan Stanley upped their price objective on Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a report on Friday, January 31st. Finally, Citigroup upped their price objective on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average price target of $139.36.
Cardinal Health Stock Down 1.0 %
CAH opened at $131.80 on Friday. The firm has a market cap of $31.84 billion, a P/E ratio of 24.59, a PEG ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $133.67. The business’s fifty day simple moving average is $127.35 and its 200 day simple moving average is $120.00.
Cardinal Health (NYSE:CAH – Get Free Report) last released its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.53%. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles
- Five stocks we like better than Cardinal Health
- What to Know About Investing in Penny Stocks
- FedEx Delivers Another Crushing Blow to Its Stock Price
- How to Profit From Value Investing
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- 5 discounted opportunities for dividend growth investors
- Micron Stock Will Retest All-Time Highs This Year
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.